94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Francesca Arezzo1,2
Gaia Giannone3*Daniele Castaldo4Giulia Scotto5Valentina Tuninetti6Margherita Turinetto5Michele Bartoletti7Serafina Mammoliti8Grazia Artioli9Giorgia Mangili10Vanda Salutari11Domenica Lorusso12Gennaro Cormio1,13Vera Loizzi1,13Claudio Zamagni14Antonella Savarese15Massimo Di Maio6Graziana Ronzino16Carmela Pisano17Sandro Pignata17Giorgio Valabrega6- 1Gynecologic Oncology Unit, IRCCS Istituto Tumori “Giovanni Paolo II”, Bari, Italy
- 2Department of Precision and Regenerative Medicine – Ionian Area, University of Bari “Aldo Moro”, Bari, Italy
- 3Department of Surgery and Cancer, Imperial College London, London, United Kingdom
- 4Segreteria Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO) Group, Naples, Italy
- 5Department of Oncology, University of Turin, Turin, Italy
- 6Department of Oncology, Mauriziano Hospital, University of Turin, Turin, Italy
- 7Unit of Medical Oncology and Cancer Prevention, Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy
- 8Ospedale Policlinico San Martino - Department of Medical Oncology, IRCCS, Genoa, Italy
- 9Oncologia Medica, Unità locale socio sanitaria n2 (ULSS2) Marca Trevigiana, Treviso, Italy
- 10Obstet-Gynecol Department, San Raffaele Scientific Institute, IRCCS, Milan, Italy
- 11Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy
- 12Department of Life Science and Public Health, Catholic University of Sacred Heart Largo Agostino Gemelli, and Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy
- 13Interdisciplinar Department of Medicine, University of Bari “Aldo Moro”, Bari, Italy
- 14Azienda Ospedaliero-universitaria di Bologna, IRCCS, Bologna, Italy
- 15Department of Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy
- 16Department of Oncology, Ospedale “Vito Fazzi”, Lecce, Italy
- 17Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale Napoli, Naples, Italy
A Corrigendum on
Management of metastatic endometrial cancer: physicians’ choices beyond the first line after approval of checkpoint inhibitors
by Arezzo F, Giannone G, Castaldo D, Scotto G, Tuninetti V, Turinetto M, Bartoletti M, Mammoliti S, Artioli G, Mangili G, Salutari V, Lorusso D, Cormio G, Loizzi V, Zamagni C, Savarese A, Di Maio M, Ronzino G, Pisano C, Pignata S and Valabrega G (2023) Front. Oncol. 13:1247291. doi: 10.3389/fonc.2023.1247291
In the published article, there was an error in affiliation 15. Instead of “Department of Oncology, Regina Elena National Cancer Institute, Rome, Italy”, it should be “Department of Oncology, IRCCS Regina Elena National Cancer Institute-Rome, Italy.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: endometrial cancer, molecular classification, immune checkpoint inhibitors, dostarlimab, pembrolizumab plus lenvatinib
Citation: Arezzo F, Giannone G, Castaldo D, Scotto G, Tuninetti V, Turinetto M, Bartoletti M, Mammoliti S, Artioli G, Mangili G, Salutari V, Lorusso D, Cormio G, Loizzi V, Zamagni C, Savarese A, Di Maio M, Ronzino G, Pisano C, Pignata S and Valabrega G (2024) Corrigendum: Management of metastatic endometrial cancer: physicians’ choices beyond the first line after approval of checkpoint inhibitors. Front. Oncol. 13:1357793. doi: 10.3389/fonc.2023.1357793
Received: 18 December 2023; Accepted: 19 December 2023;
Published: 22 January 2024.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2024 Arezzo, Giannone, Castaldo, Scotto, Tuninetti, Turinetto, Bartoletti, Mammoliti, Artioli, Mangili, Salutari, Lorusso, Cormio, Loizzi, Zamagni, Savarese, Di Maio, Ronzino, Pisano, Pignata and Valabrega. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Gaia Giannone, Zy5naWFubm9uZUBpbXBlcmlhbC5hYy51aw==